PI4K

PI4K (phosphatidylinositol 4-kinase) catalyzes the first committed steps for phosphatidylinositol 4,5-bisphosphate biosynthesis. It is associated with viral replication and cancer.

Cat.No. 产品名称 Information
GC65454 UCT943
GC65309 GSK-F1
GC62109 MMV390048
GC39155 PI-273 PI-273, the first reversibly and specific phosphatidylinositol 4-kinase (PI4KIIα) inhibitor with an IC50 of 0.47 μM, can inhibit breast cancer cell proliferation, block the cell cycle and induce cell apoptosis.
GC38033 KDU731
GC32847 PI4KIIIbeta-IN-9
GC32381 BF738735
GC32199 T-00127_HEV1
GC32163 BQR-695 (NVP-BQR695) An antimalarial compound
GC32118 KDU691 An antimalarial compound
GC30777 PI4KIIIbeta-IN-10
GC18164 UCB9608 UCB9608 是一种有效、选择性和口服活性的 PI4KIIIβ 抑制剂，IC50 为 11 nM，对 PI3KC2 α、β 和 γ 脂质激酶具有选择性。
GC13089 PIK-93 A PI4KIIIβ inhibitor
GC15508 PI4KIII beta inhibitor 3 PI4KIII beta inhibitor 3 是一种新型高效的 PI4KIIIβ 抑制剂，IC50 为 5.7 nM。